Article info
Paper
Botulinum toxin (Dysport®) treatment of hip adductor spasticity in multiple sclerosis: a prospective, randomised, double blind, placebo controlled, dose ranging study
- Dr A Richardson, Ipsen Limited, 1 Bath Road, Maidenhead, Berkshire SL6 4UH, UKalan.richardson{at}ipsen.co.uk
Citation
Botulinum toxin (Dysport®) treatment of hip adductor spasticity in multiple sclerosis: a prospective, randomised, double blind, placebo controlled, dose ranging study
Publication history
- Received March 19, 1999
- Revised November 3, 1999
- Accepted December 3, 1999
- First published June 1, 2000.
Online issue publication
June 01, 2000
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Journal of Neurology, Neurosurgery, and Psychiatry